Evidence map›Paper›PMID 33326107›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Using Zebrafish Larvae as a Xenotransplantation Model to Study Ewing Sarcoma.

Susana Pascoal, Sarah Grissenberger, Eva Scheuringer, Rita Fior, Miguel Godinho Ferreira, Martin Distel

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Susana PascoalInnovative Cancer Models, St. Anna Children's Cancer Research Institute, Vienna, Austria.
Sarah GrissenbergerInnovative Cancer Models, St. Anna Children's Cancer Research Institute, Vienna, Austria.
Eva ScheuringerInnovative Cancer Models, St. Anna Children's Cancer Research Institute, Vienna, Austria.
Rita FiorChampalimaud Centre for the Unknown, Champalimaud Foundation, Lisbon, Portugal.
Miguel Godinho FerreiraInstitute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur, Nice Cedex 2, France.
Martin DistelInnovative Cancer Models, St. Anna Children's Cancer Research Institute, Vienna, Austria. martin.distel@ccri.at.
St. Anna Children's Cancer Research InstituteSt Anna Children's Hospital · ATChampalimaud Foundation · PTInstitut de Recherche sur le Cancer et le Vieillissement de Nice · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor models allowing for the in vivo investigation of molecular mechanisms driving tumor progression and metastasis are important to develop novel strategies for cancer treatment. Unfortunately, for Ewing sarcoma no adequate genetic animal models are currently available. Mouse xenograft models are the state of the art to model Ewing sarcoma in vivo. Here, we describe an alternative Ewing sarcoma xenograft model in embryonic and larval zebrafish. This xenograft model offers live imaging and easy compound testing opportunities hereby complementing mouse xenograft models. In this chapter, we provide a detailed protocol how to xenograft Ewing sarcoma cells (shSK-E17T) into 2-day-old zebrafish and how xenografted zebrafish can be imaged and analyzed over consecutive days to study tumor proliferation.

Indexed as

Disease Models, AnimalTransplantation, HeterologousAnimalsBiomarkersBone NeoplasmsCell Line, TumorImmunohistochemistryLarvaSarcoma, EwingZebrafishBiomarkersEwing sarcomaLive imagingMetastasisTumor modelXenotransplantationZebrafish

Identifiers

PMID33326107
OpenAlexW3112621062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.